| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:CB-86
CAS:1150586-64-3
Purity:98% Remarks:Cannabinoid receptors (CB) are of a class of cell membrane receptors in the G protein-coupled receptor superfamily. CB-86 is a resorcinol-anandamide hybrid compound that acts as a partial agonist for
|
| Company Name: |
LETOPHARM LIMITED
|
| Tel: |
+86-21-5821 5861 |
| Email: |
sales@letopharm.com |
| Products Intro: |
Product Name:CB-86
CAS:1150586-64-3
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing1@energy-chemical.com |
| Products Intro: |
Product Name:CB-86
CAS:1150586-64-3
Purity:NULL Package:1mg;2.5mg Remarks:NULL
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:CB-86
CAS:1150586-64-3
Purity:98% Package:1mg;5mg;10mg
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:CB-86
CAS:1150586-64-3
Package:>=98% Remarks:13289
|
|
| Product Name: | CB-86 | | Synonyms: | CB-86;Octanamide, N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]- | | CAS: | 1150586-64-3 | | MF: | C26H43NO3 | | MW: | 417.62 | | EINECS: | | | Product Categories: | | | Mol File: | 1150586-64-3.mol |  |
| | CB-86 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS (pH 7.2)(1:2): 0.3 mg/ml |
| | CB-86 Usage And Synthesis |
| Description | CB-86 is a resorcinol-anandamide hybrid compound that acts as a partial agonist for the central cannabinoid (CB1) receptor and a neutral antagonist for the peripheral cannabinoid (CB2) receptor with Ki values of 5.6 and 7.9 nM, respectively.1 Its demonstrated potency is similar to that of WIN 55,212-2 (Ki = 21 and 2.1 nM for CB1 and CB2, respectively).1 CB-86 (1 mg/kg) exhibits antinociceptive effects in mice treated with formalin.1 | | References | 1. Brizzi, A., Brizzi, V., Cascio, M.G., et al. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo J. Med. Chem. 52,2506-2514(2009). |
| | CB-86 Preparation Products And Raw materials |
|